Sign Up to like & get
recommendations!
0
Published in 2018 at "ACS infectious diseases"
DOI: 10.1021/acsinfecdis.8b00011
Abstract: New Delhi metallo-β-lactamase-1 (NDM-1) is the major contributor to the emergence of carbapenem resistance in Gram-negative pathogens (GNPs) and has caused many clinically available β-lactam antibiotics to become obsolete. A clinically approved inhibitor of metallo-β-lactamase…
read more here.
Keywords:
inhibitor;
gram negative;
meropenem activity;
negative pathogens ... See more keywords